Pyxis Oncology Inc
PYXS
$1.80+0.56%
End of day · as of Oct 16, 2026, 2:01 AM ET
Mkt cap
$109.60M
EV/Sales
6.80
P/E ratio
N/A
FY2025 Revenue
$13.86M
EPS (TTM)
$-1.40
Gross Margin (FY2025)
82.77%
Profit Margin (FY2025)
-574.55%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported PYXS revenue for 2025-12-31 was $13.9M. Net income was -$79.6M. PYXS currently screens at market cap $109.6M.
Use this PYXS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PYXS income, balance, and cash tables.
Pyxis Oncology Inc (PYXS) is a biotechnology company in the Healthcare sector.
Latest cached Pyxis Oncology Inc (PYXS) revenue for Dec 31, 2025 was $13.9M. Net income was -$79.6M. Statements: https://lician.com/financials/pyxs
Pyxis Oncology Inc (PYXS) market capitalization is $109.6M on the latest cached snapshot.
Pyxis Oncology Inc (PYXS) cached previous close $1.79; day range $1.79 – $1.81; volume 515,013. Session quote: https://lician.com/quote/pyxs
Pyxis Oncology Inc (PYXS) latest cached earnings event is "PYXS earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PYXS filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/pyxs